These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22143953)

  • 21. An evaluation of inpatient treatment continuation and hospital readmission rates in patients with bipolar disorder treated with aripiprazole or quetiapine.
    Kreys TJ; Fabian TJ; Saul MI; Haskett R; Coley KC
    J Psychiatr Pract; 2013 Jul; 19(4):288-95. PubMed ID: 23852103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007).
    El Mallakh RS; Vieta E; Rollin L; Marcus R; Carson WH; McQuade R
    Eur Neuropsychopharmacol; 2010 Nov; 20(11):776-83. PubMed ID: 20728318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial.
    Woo YS; Bahk WM; Chung MY; Kim DH; Yoon BH; Lee JH; Ahn YM; Chung SK; Kim JG; Lee KH; Paik KC
    Hum Psychopharmacol; 2011 Dec; 26(8):543-53. PubMed ID: 22134973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjunctive aripiprazole in bipolar I depression.
    Sokolski KN
    Ann Pharmacother; 2007 Jan; 41(1):35-40. PubMed ID: 17190849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.
    Tramontina S; Zeni CP; Ketzer CR; Pheula GF; Narvaez J; Rohde LA
    J Clin Psychiatry; 2009 Apr; 70(5):756-64. PubMed ID: 19389329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression.
    Dunn RT; Stan VA; Chriki LS; Filkowski MM; Ghaemi SN
    J Affect Disord; 2008 Sep; 110(1-2):70-4. PubMed ID: 18272230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the safety and tolerability of aripiprazole.
    Pae CU
    Expert Opin Drug Saf; 2009 May; 8(3):373-86. PubMed ID: 19505266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study.
    Findling RL; Correll CU; Nyilas M; Forbes RA; McQuade RD; Jin N; Ivanova S; Mankoski R; Carson WH; Carlson GA
    Bipolar Disord; 2013 Mar; 15(2):138-49. PubMed ID: 23437959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance.
    de Bartolomeis A; Perugi G
    Expert Opin Pharmacother; 2012 Oct; 13(14):2027-36. PubMed ID: 22946707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of antipsychotic-induced tardive dyskinesia with aripiprazole in an elderly patient with bipolar I disorder.
    Wu WY; Chan HY; Tan HK
    Acta Neuropsychiatr; 2014 Feb; 26(1):61-4. PubMed ID: 25142102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effectiveness and safety of adjunctive aripiprazole in Taiwanese patients with antidepressant-refractory major depressive disorder: a prospective, open-label trial.
    Chen SJ; Hsiao YL; Shen TW; Chen ST
    J Clin Psychopharmacol; 2012 Feb; 32(1):56-60. PubMed ID: 22198444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aripiprazole for the maintenance treatment of bipolar I disorder: A review.
    McIntyre RS
    Clin Ther; 2010; 32 Suppl 1():S32-8. PubMed ID: 20152551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study.
    Sachs G; Sanchez R; Marcus R; Stock E; McQuade R; Carson W; Abou-Gharbia N; Impellizzeri C; Kaplita S; Rollin L; Iwamoto T;
    J Psychopharmacol; 2006 Jul; 20(4):536-46. PubMed ID: 16401666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aripiprazole augmentation for major depressive disorder: dosing patterns in a naturalistic treatment setting.
    Pae CU; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS
    Int Clin Psychopharmacol; 2014 Mar; 29(2):116-9. PubMed ID: 24108149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
    Kaneriya SH; Robbins-Welty GA; Smagula SF; Karp JF; Butters MA; Lenze EJ; Mulsant BH; Blumberger D; Anderson SJ; Dew MA; Lotrich F; Aizenstein HJ; Diniz BS; Reynolds CF
    JAMA Psychiatry; 2016 Apr; 73(4):329-36. PubMed ID: 26963689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aripiprazole for the treatment of bipolar disorder: a review of current evidence.
    Fagiolini A; Nitti M; Forgione RN; Marra FS; Casamassima F
    Expert Opin Pharmacother; 2011 Feb; 12(3):473-88. PubMed ID: 21254952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aripiprazole in acute mania and long-term treatment of bipolar disorder: a critical review by an Italian working group.
    De Fazio P; Girardi P; Maina G; Mauri MC; Mauri M; Monteleone P; Perini GI; Perugi G; Rossi A
    Clin Drug Investig; 2010; 30(12):827-841. PubMed ID: 20923242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial.
    Mischoulon D; Witte J; Levy M; Papakostas GI; Pet LR; Hsieh WH; Pencina MJ; Ward S; Pollack MH; Fava M
    J Clin Psychiatry; 2012 Mar; 73(3):353-7. PubMed ID: 21939613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bupropion as an add-on therapy in depressed bipolar disorder type I patients with comorbid cocaine dependence.
    Sepede G; Di lorio G; Lupi M; Sarchione F; Acciavatti T; Fiori F; Santacroce R; Martinotti G; Gambi F; Di Giannantonio M
    Clin Neuropharmacol; 2014; 37(1):17-21. PubMed ID: 24434527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole for the treatment of acute manic or mixed episodes in Asian patients with bipolar I disorder (the AMAZE study).
    Kanba S; Kawasaki H; Ishigooka J; Sakamoto K; Kinoshita T; Kuroki T
    World J Biol Psychiatry; 2014 Feb; 15(2):113-21. PubMed ID: 22540407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.